Home » Topics » Regulatory

Regulatory
RSS

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Effective use of transdermal buprenorphine in cancer and noncancer pain

May 9, 2003

Vioxx approved in Canada for use in rheumatoid arthritis

May 9, 2003

New Risperdal formulation launched

May 8, 2003

Extended-release ciprofloxacin in complicated urinary tract infections

May 8, 2003

Forest seeks label expansion for Lexapro to include panic disorder

May 6, 2003

FDA approves more convenient formulation of Viracept

May 6, 2003

FDA approves Aldurazyme for MPS I

May 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...